Re: Separation from Employment and General ReleaseDiffusion Pharmaceuticals Inc. • May 19th, 2023 • Pharmaceutical preparations
Company FiledMay 19th, 2023 IndustryThis letter agreement and general release (this “Agreement”) sets forth the terms of your separation from employment with Diffusion Pharmaceuticals Inc. (together with its subsidiaries, “Diffusion” or the “Company”) effective May 15, 2023 (the “Separation Date”). References in this Agreement to “you” and “your” refer to Mr. William Hornung.
Re: Separation from Employment and General ReleaseDiffusion Pharmaceuticals Inc. • May 19th, 2023 • Pharmaceutical preparations
Company FiledMay 19th, 2023 IndustryThis letter agreement and general release (this “Agreement”) sets forth the terms of your separation from employment with Diffusion Pharmaceuticals Inc. (together with its subsidiaries, “Diffusion” or the “Company”) effective May 15, 2023 (the “Separation Date”). References in this Agreement to “you” and “your” refer to Mr. William Hornung.
Re: Separation from Employment and General Release Dear Chris,Diffusion Pharmaceuticals Inc. • March 24th, 2023 • Pharmaceutical preparations
Company FiledMarch 24th, 2023 IndustryThis letter agreement and general release (this “Agreement”) sets forth the terms of your separation from employment with Diffusion Pharmaceuticals Inc. (together with its subsidiaries, “Diffusion” or the “Company”) effective March 1, 2023 (the “Separation Date”). References in this Agreement to “you” and “your” refer to Dr. Christopher D. Galloway, M.D.